Recombinant PCSK9 (Lodelcizumab Biosimilar) antibody

Catalog No. ABIN7597794

This Humanized Chimeric antibody specifically detects PCSK9 (Lodelcizumab Biosimilar) in not_set. It exhibits reactivity toward Human.

Quick Overview for Recombinant PCSK9 (Lodelcizumab Biosimilar) antibody (ABIN7597794)

Target: PCSK9 (Lodelcizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This PCSK9 (Lodelcizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-PCSK9 (Lodelcizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Lodelcizumab Biosimilar Antibody

Specificity: Proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9, NARC-1, PC9, Proprotein convertase 9, Neural apoptosis-regulated convertase 1, NARC1, PCSK9

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for PCSK9 (Lodelcizumab Biosimilar)

Target: PCSK9 (Lodelcizumab Biosimilar)

Alternative Name: Lodelcizumab Biosimilar

Target Type: Biosimilar

Background: Proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9, NARC-1, PC9, Proprotein convertase 9, Neural apoptosis-regulated convertase 1, NARC1, PCSK9

UniProt: Q8NBP7

CAS-No: 1355338-54-3